Medical Value and Access Field Director, Regional Accounts
Amgen
Summary
In this vital role you will lead therapeutically aligned activities to develop strategic objectives & tactics in prioritized regional accounts and IDNs.
Job description
Responsibilities
- Effectively leads a regional payer team of Medical Value & Access Liaisons (MVALs) toward the implementation of field medical payer activities by communicating expectations and guiding the team to optimize medical strategy, prioritization and performance in support of medical objectives
- Ensure the team achieves legally compliant and clinically significant scientific engagements and activities with population health decision-makers, payers, Integrated Delivery Networks (IDNs) and other healthcare partners in accordance with all applicable laws, regulations, industry codes, and the Amgen Code of Conduct
- Strategic leader who develops and maintains professional relationships with targeted Payer & Integrated Delivery Networks (IDN) population health decision makers relative to the Amgen Oncology, Inflammation, Gen Med & Rare Disease portfolio
- Accompany the team to engagements with healthcare decision-makers and other healthcare collaborators to assess strengths, proficiency and provide timely and constructive performance feedback
- Familiar with data & biotechnology techniques to accelerate health outcomes through enhanced patient identification & access, with a reimagined customer experience
- Apply interactive, aligned discussions, and guided activities to help the team identify career opportunities for growth and leadership within and beyond the Medical Liaison role
- Lead and coordinate MVAL team meetings to support team building, best practice sharing, development, retaining top talent, and the accomplishment of field medical objectives
- Build upon positive relationships and cross-functional collaboration with key internal collaborators in Global Medical, US Field Sales, Value and Access and Value Marketing teams to facilitate a One-Amgen customer-facing engagement strategy and champion the value of the MVAL team
- Identify, interview, hire, and onboard qualified MVALs to create a diverse and inclusive team
- Assess MVAL new hire field readiness by assisting Global Learning and Performance in the Amgen portfolio, Payer & healthcare landscape, disease state, and product training, including assistance with post-training proficiency assessment
- Assist Medical leadership in the development of the field medical strategy, tactical goals and objectives, and Scientific Engagement Plans (SEPs)
- Support the strategic planning and field medical value implementation of Managed Care/Payer and national congresses
- Leads integration of comprehensive value & total cost of care models with MVAL team to enhance the level of internal/external payer & IDN engagements
- Liaises and supports strategic relationship between targeted IDN, National and Regional payer executives and senior Amgen executives
- Synthesizes customer insights to inform short- and long-term strategy and integrates customer-specific research needs into evidence generation plans
- Participates in value-based strategy discussions with Market Access for payer & IDN engagements
- Travel is required (~50%)
Basic Qualifications
- Doctorate degree and 4 years of Medical Science Liaison and/or Payer/PBM experience or Master's degree and 7 years of Medical Science Liaison and/or Payer/PBM experience or Bachelor's degree and 9 years of Medical Science Liaison and/or Payer/PBM experience
Preferred Qualifications
- Pharm.D., Ph.D., M.D., D.O. or Master's Degree (Other Doctoral & Master's Degrees considered)
- ≥ 5 years of related Payer/PBM/Pathways/Trade/Specialty Pharmacy customer experience
- ≥ 2 years IDN Group Purchasing Organization (GPO) experience
- Evidence of significant impact & rapport with Payer & IDN accounts
- Proven leadership experience & demonstrated ability to inspire, coach & develop talent
- Experienced in establishing Value Based Partnership initiatives with Payer & IDN accounts
- Understands the value of data, technology & digital platforms to shape the future of biotechnology by blending cutting-edge technology with our scientific expertise
- Deep knowledge of managed markets, pharmacoeconomics, population health and broad healthcare & healthcare policy/legislation trends
- Excellent strategic perspective, communication and presentation skills
- Inspiring background of partnering with Medical & Commercial cross-functional colleagues to provide value to customers
Requirements
- Doctorate degree and 4 years of Medical Science Liaison and/or Payer/PBM experience, or Master's degree and 7 years of Medical Science Liaison and/or Payer/PBM experience, or Bachelor's degree and 9 years of Medical Science Liaison and/or Payer/PBM experience
- Pharm.D., Ph.D., M.D., D.O. or Master's Degree preferred
- ≥ 5 years of related Payer/PBM/Pathways/Trade/Specialty Pharmacy customer experience preferred
- ≥ 2 years IDN Group Purchasing Organization (GPO) experience preferred
- Proven leadership experience & demonstrated ability to inspire, coach & develop talent
- Deep knowledge of managed markets, pharmacoeconomics, population health and healthcare policy/legislation trends
- Excellent strategic perspective, communication and presentation skills
- Travel is required (~50%)
Benefits
- Retirement & Savings Plan
- Medical, Dental & Vision
- Life & Disability Insurance
- Flexible Spending Accounts
- Annual Bonus Program
- Stock-Based Long-Term Incentives
- Paid Time Off
- Flexible Work Models
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.